ADAPTIVE BIOTECHNOLOGIES
Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clone-SEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. It was founded in 2009 and headquartered in Seattle, Washington.
ADAPTIVE BIOTECHNOLOGIES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.adaptivebiotech.com
Total Employee:
501+
Status:
Active
Contact:
(206) 659-0067
Email Addresses:
[email protected]
Total Funding:
531.85 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network SSL By Default Organization Schema Cloudflare Hosting
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-01-07 | Sequenta | Sequenta acquired by Adaptive Biotechnologies | N/A |
Investors List
OrbiMed
OrbiMed investment in Post-IPO Debt - Adaptive Biotechnologies
ARK Investment Management
ARK Investment Management investment in Post-IPO Equity - Adaptive Biotechnologies
Sweetwater Capital Partners
Sweetwater Capital Partners investment in Post-IPO Equity - Adaptive Biotechnologies
EquityZen
EquityZen investment in Secondary Market - Adaptive Biotechnologies
Senator Investment Group
Senator Investment Group investment in Series F - Adaptive Biotechnologies
Tiger Management Corporation
Tiger Management Corporation investment in Series F - Adaptive Biotechnologies
Matrix Capital Management
Matrix Capital Management investment in Series F - Adaptive Biotechnologies
Rock Springs Capital
Rock Springs Capital investment in Series F - Adaptive Biotechnologies
Viking Global Investors
Viking Global Investors investment in Series D - Adaptive Biotechnologies
Viking Global Investors
Viking Global Investors investment in Series C - Adaptive Biotechnologies
Key Employee Changes
Official Site Inspections
http://www.adaptivebiotech.com Semrush global rank: 2.83 M Semrush visits lastest month: 5.94 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Adaptive Biotechnologies"
Who We Are - Adaptive Biotech
In 2009, Harlan Robins made a breakthrough that created a window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded …See details»
Our Story - Adaptive Biotech
Our Innovation Timeline. Just as our immune systems have evolved, shaped by our environment and biology, so has Adaptive Biotechnologies. Our progress has accelerated our ability to read …See details»
Adaptive Biotechnologies - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (206) 659-0067 Adaptive Biotechnologies is a commercial-stage company advancing the field of immune-driven …See details»
Adaptive Biotechnologies Corp. | LinkedIn
Https://www.adaptivebiotech.com 35 Like Comment Share Adaptive Biotechnologies Corp. 29,458 followers 1mo Report this post Last week, Adaptive's PRIDE ERG hosted our 4th Annual Coming Out Day ...See details»
Investor Relations | Adaptive Biotechnologies
About Adaptive Biotechnologies. Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into …See details»
Press Release Details - Adaptive Biotechnologies
Apr 9, 2020 “We are excited to further expand our executive leadership team as we scale our organization and accelerate the development and commercialization of clinical products …See details»
Press Release Details - investors.adaptivebiotech.com
New Partnership with Youth Organization STEM Paths Innovation Network (SPIN) Seeds Next Generation of Local Biotech Talent. SEATTLE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- …See details»
Adaptive Biotechnologies Provides Strategic Review Update and …
Apr 2, 2024 Announces CFO transitionSEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology …See details»
Adaptive Biotechnologies Provides Strategic Review Update and
Apr 2, 2024 ADAPTIVE INVESTORS Karina Calzadilla, Vice President, Investor [email protected] ADAPTIVE MEDIA Erica Jones , Associate …See details»
Adaptive Biotechnologies Announces Grand Opening of State-of …
Sep 21, 2021 New Partnership with Youth Organization STEM Paths Innovation Network (SPIN) Seeds Next Generation of Local Biotech Talent. SEATTLE, Sept. 21, 2021 (GLOBE …See details»
Adaptive Biotechnologies Announces FDA Acceptance of …
May 9, 2023 Adaptive Biotechnologies. The T-Cell Therapy product candidate contains a neoantigen-specific T-cell receptor (TCR) identified and characterized through Adaptive’s TCR …See details»
Platform - Adaptive Biotech
Finding the answers within us. Our Immune Medicine Platform makes the adaptive immune system accessible by applying proprietary chemistry, computational biology and machine …See details»
Keep up to date with Adaptive - Adaptive Biotechnologies
SEATTLE, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that translates the genetics of …See details»
Adaptive Biotechnologies Announces Grand Opening of
Sep 21, 2021 New Partnership with Youth Organization STEM Paths Innovation Network (SPIN) Seeds Next Generation of Local Biotech Talent. September 21, 2021 16:05 ET | Source: …See details»
Adaptive Biotechnologies and Microsoft launch groundbreaking …
Jun 11, 2020 ImmuneCODE is an open database that provides a detailed population-level view into the adaptive immune response to the COVID-19 virus. Adaptive Biotechnologies and …See details»
Adaptive Biotechnologies and Microsoft expand partnership to …
Mar 20, 2020 Its mission is to empower every person and every organization on the planet to achieve more. ... [email protected] or Beth Keshishian, Adaptive Media, (917) 912-7195, …See details»
Timeline - Adaptive Biotech
Timeline. Scroll through Adaptive Biotechnologies’ timeline and learn how we have arrived at the precipice of transforming medicine. Our milestones show how we are harnessing the natural …See details»
Amgen And Adaptive Biotechnologies Announce Strategic …
Apr 2, 2020 Adaptive Extends Immune Medicine Platform to Discover Therapeutic Antibodies From Recovered COVID-19 Patients Amgen Will Leverage Genetics, Immunology, Antibody …See details»
Drug Discovery Pipeline - Adaptive Biotech
1 Product candidates in development as part of our worldwide collaboration and license agreement with Genentech. The first shared and second shared cell therapy product …See details»